Report indicates shift in strategy

Share this article:
A report released by Best Practices indicates that leading pharma and biopharmaceutical companies are rethinking their publication strategies, in light of new transparency guidelines.

“Traditional, global peer-reviewed journals remain the first choice of most companies at all phases of product development, but companies are increasingly exploring alternative media for scientific publications—50% of benchmark participants said they will be increasing the percentage of articles they submit to alternative media, such as e-journals, compared with 36% increasing submission to peer-reviewed journals,” said Martha Haswell, senior research analyst at Best Practices. 
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"